Hydrogel vaccines consisting of GM–CSF, CPG–ODN, TLR9 agonists, and tumor cell lysates have important clinical value, as they provide local sustained release antigens and adjuvant activation of dendritic cells. Here, CSF2 is linked to neoplasm.